Browsing by Subject "workforce"

Now showing 1 - 4 of 4
  • Thumbnail Image
    ItemOpen Access
    Black Box Warning: Large Language Models and the Future of Infectious Diseases Consultation.
    (Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2023-11) Schwartz, Ilan S; Link, Katherine E; Daneshjou, Roxana; Cortés-Penfield, Nicolás
    Large language models (LLMs) are artificial intelligence systems trained by deep learning algorithms to process natural language and generate text responses to user prompts. Some approach physician performance on a range of medical challenges, leading some proponents to advocate for their potential use in clinical consultation and prompting some consternation about the future of cognitive specialties. However, LLMs currently have limitations that preclude safe clinical deployment in performing specialist consultations, including frequent confabulations, lack of contextual awareness crucial for nuanced diagnostic and treatment plans, inscrutable and unexplainable training data and methods, and propensity to recapitulate biases. Nonetheless, considering the rapid improvement in this technology, growing calls for clinical integration, and healthcare systems that chronically undervalue cognitive specialties, it is critical that infectious diseases clinicians engage with LLMs to enable informed advocacy for how they should-and shouldn't-be used to augment specialist care.
  • Thumbnail Image
    ItemOpen Access
    Should You Stay or Should You Go? Strategies for stabilizing your curent job or migrating to a new career if it's time to leave.
    (Emergency Physicians Monthly, 2022-06-21) Severance, Harry
    Strategies for stabilizing your current job or migrating to a new career if it’s time to leave.
  • Thumbnail Image
    ItemOpen Access
    Standardization, workforce development and advocacy in cell and gene therapies: a summary of the 2020 Regenerative Medicine InterCHANGE.
    (Cytotherapy, 2021-10) McNiece, Ian K; Wacker, Kara K; Kurtzberg, Joanne; Warkentin, Phyllis I
    Cell and gene therapy is a promising and disruptive new field of medicine for diseases lacking effective treatments. Collaboration among stakeholders has become critically important as investigators, health care providers, manufacturers, couriers, data registries, regulators and payers all become more invested in the success of this field. Many organizations have collaborated with each other to increase clarity, advocate for improvements and share lessons learned. These efforts appear to be making an impact, although the potential for duplicative efforts could slow progress. The second Regenerative Medicine InterCHANGE, hosted by the Foundation for the Accreditation of Cellular Therapy, took place at the Phacilitate Leaders World/World Stem Cell Summit conference in Miami, Florida, on January 24, 2020. Participants from several organizations outlined needs to advance cell and gene therapies. Efforts to address these include standardization, workforce development and advocacy. This article summarizes the major challenges and opportunities discussed during the InterCHANGE.
  • Thumbnail Image
    ItemOpen Access
    US Healthcare System is a House of Cards; Could it Collapse?
    (Duke Medium, 2022-08-02) Severance, Harry